3Brepoels L,Stroobants S,Verhoef G.PET and PET-CT for response evaluation in lymphoma:current practice and developments[J].Leukemia Lymphoma,2007,48(2):207-282.
4Reske SN.PET and restaging of malignant lymphoma including residual masses and relapse[J].Eur J Nucl Med Mol Imaging,2003,30(Suppl 1):S89-S96.
6Raanani P,Shasha Y,Perry C,et al.Is CT scan still necessary for staing in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era[J].Ann Oncol,2006,17(1):117-122.
7Allen-Auerbach M,Quon A,Weber WA,et al.Comparison between 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography andpes itmn emission tomography/computed tomography hardware fusion for staging of patients with lymphoma[J].Mol Imaging Biol,2004,6(6):411-416.
8Isasi CR,Lu P,Blaufox MD.A meta analysis of 18F-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma[J].Cancer,2005,104(5):1066-1074.
10Thill R,Neuerburg J,Fabry U,et al.Comparison of findings with F-FDG PET and CT in pretherapeutie staging of malignant lymphoma[J].Nukeannedizin,1997,36(7):234-239.
3Brepoels L, Stroobants S, Verhoef G. PET and PET/CT for response evaluation in lymphoma: current practice and developments[J]. Leukemia Lymphoma, 2007, 48(2): 270-282.
4Reske SN. PET and restaging of malignant lymphoma including residual masses and relapse [J]. Eur J Nucl Meal Mol Imaging, 2003, 30(Suppl 1): S89-S96.
5Furth C, Denecke T, Steffen I, et al. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease [J]. J Pediatr Hematol/Oncol, 2006, 28 (8): 501- 512.
6Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N, et al. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma[J]. Br J Haematol, 2006, 135(3): 293-302.
7Tani M, Stefoni V, Canini R, et al. ^18F-FDG PET in malignant lymphoma: significance of positive findings [J]. Eur J Nucl Med Mol Imaging, 2005, 32(7): 749-756.
8Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?[J]. Ann Oneol, 2005, 28(17): 117-122.
9Isasi CR, Lu P, Blaufox MD. A meta analysis of ^18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma [J]. Cancer, 2005, 104(5): 1066-1074.
10Allen-Auerbach M, Quon A, Weber WA, et al. Comparison between 2-deoxy-2-[^18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma [J]. Mol Imaging Biol, 2004, 6(6): 411-416.
